Otitis Media Has Impact on Auditory, Language Development
09 Jan 2024
TUESDAY, Jan. 9, 2024 -- Otitis media seems to affect auditory and language development, according to a study published in the January issue of the International Journal of Pediatric Otorhinolaryngology.
Noting that evidence relating to the effect of otitis media on auditory and language development has been contradictory, Susan Nittrouer, Ph.D., and Joanna H. Lowenstein, Ph.D., from the University of Florida in Gainesville, examined these effects in more detail in a study of 49 children aged 5 to 10 years with and 68 without significant histories of otitis media. Temporal modulation detection was used to examine auditory function, using games to maintain children's attention; language measures included measures of lexical knowledge and phonological sensitivity.
The researchers found that across groups of children with and without histories of otitis media, sustained attention was demonstrated. Performance was poorer for children with versus without histories of otitis media on the auditory measure and on both sets of language measures; stronger effects were seen for phonological sensitivity than lexical knowledge. Variability in phonological sensitivity, but not in lexical knowledge, was accounted for by deficits in temporal modulation.
"Ear infections are so common that we tend to dismiss them as having no long-term effect. We should take all ear infections seriously," Nittrouer said in a statement. "Parents should be aware that their child may have some middle ear fluid without it being painful and work with their doctor to monitor their child closely."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.